DASH vs SRPT · P/E 76, rev $13.72B vs rev $1.90B
DoorDash, Inc. Class A Common Stock (DASH) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the DASH and SRPT stock pages for the full models.
Not investment advice.